(51) showed that the combination of ferumoxytol and CpG oligodeoxynucleotide 2395 could effectively suppress EGFR and its downstream AKT/mTOR signaling pathway, thereby enhancing the antitumor activity of macrophages in NSCLC with EGFR mutation. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.